Trial record 1 of 1 for:    study of hydroxychloroquine in combination with FOLFOX plus bevacizumab to inhibit autophagy in colorectal cancer
Previous Study | Return to List | Next Study

FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Abramson Cancer Center of the University of Pennsylvania
Sponsor:
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT01206530
First received: September 16, 2010
Last updated: January 21, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)